Linda Baddour serves as Executive at PHARMACEUTICAL PRODUCT DEVELOPMENT INC, where they oversee executive responsibilities. Since joining the company, Linda Baddour has executed 176 insider transactions totaling $48.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 17, 2024 involved receiving (via award) 12,845 shares valued at $0.
Linda Baddour currently holds 34,535 shares of PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Linda Baddour has been a net seller of PPDI stock. They have purchased $0 and sold $48.6M worth of shares.
Linda Baddour's most recent insider trade was on May 17, 2024, when they sold 12,845 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 13, 2024 | WAT | $177.8K | Sale | 500 | $355.54 | Discretionary |
| Jan 2, 2024 | WAT | $0 | Award | 334 | $N/A | Discretionary |
| May 12, 2023 | CYRX | $0 | Award | 8,105 | $N/A | Discretionary |
| Mar 15, 2023 | CYRX | $0 | Option Exercise | 1,111 | $N/A | Discretionary |
| Jan 3, 2023 | WAT | $0 | Award | 318 | $N/A | Discretionary |
| Apr 30, 2022 | CYRX | $0 | Option Exercise | 2,708 | $N/A | Discretionary |
| Apr 29, 2022 | CYRX | $0 | Award | 7,203 | $N/A | Discretionary |
| Mar 15, 2022 | CYRX | $0 | Option Exercise | 1,111 | $N/A | Discretionary |
| Jan 3, 2022 | WAT | $109.7K | Award | 301 | $364.59 | Discretionary |
| Aug 16, 2021 | WAT | $231.1K | Option Exercise | 1,260 | $183.41 | Discretionary |
| Aug 16, 2021 | WAT | $515.3K | Sale | 1,260 | $408.99 | Discretionary |
| May 13, 2021 | WAT | $393.4K | Sale | 1,249 | $314.99 | Discretionary |
| May 13, 2021 | WAT | $235.1K | Option Exercise | 1,249 | $188.26 | Discretionary |
| Apr 29, 2021 | CYRX | $0 | Option Exercise | 341 | $N/A | Discretionary |
| Jan 4, 2021 | WAT | $0 | Award | 439 | $N/A | Discretionary |
| Jan 2, 2020 | WAT | $0 | Award | 467 | $N/A | Discretionary |
| Jan 2, 2019 | WAT | $0 | Award | 599 | $N/A | Discretionary |
| Sep 4, 2018 | WAT | $0 | Award | 292 | $N/A | Discretionary |
| Jan 16, 2018 | PRAH | $5.8M | Sale | 64,405 | $90.26 | Discretionary |
| Jan 16, 2018 | PRAH | $785.9K | Option Exercise | 67,000 | $11.73 | Discretionary |
| Jan 16, 2018 | PRAH | $235.0K | Sale | 2,595 | $90.56 | Discretionary |
| Aug 14, 2017 | PRAH | $7.5M | Sale | 100,000 | $74.85 | Discretionary |
| Aug 8, 2017 | PRAH | $1.2M | Option Exercise | 100,000 | $11.73 | Discretionary |
| Apr 17, 2017 | PRAH | $365.9K | Option Exercise | 124,472 | $2.94 | Discretionary |
| Apr 17, 2017 | PRAH | $7.9M | Sale | 124,472 | $63.59 | Discretionary |
| Apr 17, 2017 | PRAH | $843.6K | Option Exercise | 71,921 | $11.73 | Discretionary |
| Apr 17, 2017 | PRAH | $4.6M | Sale | 71,921 | $63.59 | Discretionary |
| Aug 15, 2016 | PRAH | $204.0K | Option Exercise | 69,380 | $2.94 | Discretionary |